Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Understanding the key features of no annual fee cards can help you maximize benefits. Discover what to prioritize for your financial needs.
18,760 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
New home sales edged lower in December but remain near multiyear highs at 745,000 SAAR, driven by financing incentive...
A neighbor’s request to borrow a snowblower tests whether sharing costly equipment makes financial sense. The article...
Suze Orman promotes a staged investing plan for people with large cash cushions, favoring dollar-cost averaging into ...
International stocks winning again is moving from headlines to portfolio reality as ex-US ETFs post strong gains and ...
A viral AI video about a famed athlete sparked more than headlines—it spotlighted money risks and smart financial hab...
Analysts upgrade CrowdStrike ahead of earnings, citing modest guidance risk and a software sector pullback that has w...
Automation investments in 2026 are reshaping how firms think about labor. This piece examines the provocative idea th...
President Trump unveils a White House pledge inviting hyperscalers to back on-site power generation to ease data cent...
Strategy Inc. escalated its Bitcoin purchases with a $1.3 billion bet funded largely by new common shares and STRC pr...
A federal audit alleges medicare advantage insurers overcharging taxpayers via inflated risk scores. Investors are re...
Uber expands its autonomous-vehicle ambitions by teaming up with Zoox, clouding the landscape with more AV partners a...